Skip to main content

and
  1. Article

    Open Access

    Mouse serum albumin induces neuronal apoptosis and tauopathies

    The elderly frequently present impaired blood–brain barrier which is closely associated with various neurodegenerative diseases. However, how the albumin, the most abundant protein in the plasma, leaking throu...

    Sheng-jie Hou, Ya-ru Huang, Jie Zhu, Ying-bo Jia in Acta Neuropathologica Communications (2024)

  2. Article

    Open Access

    Thrombomodulin reduces α-synuclein generation and ameliorates neuropathology in a mouse model of Parkinson’s disease

    The neurotoxic α-synuclein (α-syn) oligomers play an important role in the occurrence and development of Parkinson’s disease (PD), but the factors affecting α-syn generation and neurotoxicity remain unclear. W...

    **ao-yun Niu, **-xiu **e, Hou-zhen Tuo, Cui-** Lv, Ya-ru Huang in Cell Death Discovery (2024)

  3. Article

    Open Access

    Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer’s disease-like mouse model

    Passive immunotherapy is one of the most promising interventions for Alzheimer’s disease (AD). However, almost all immune-modulating strategies fail in clinical trials with unclear causes although they attenua...

    **ao-ying Sun, **ao-lin Yu, Jie Zhu in Signal Transduction and Targeted Therapy (2023)

  4. Article

    Open Access

    Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease

    Tau pathology is a hallmark of Alzheimer’s disease (AD) and other tauopathies. During disease progression, abnormally phosphorylated forms of tau aggregate and accumulate into neurofibrillary tangles, leading ...

    **ao-ying Sun, Ling-jie Li, Quan-**u Dong, Jie Zhu in Journal of Neuroinflammation (2021)

  5. No Access

    Article

    Efficient delivery of clay-based nanovaccines to the mouse spleen promotes potent anti-tumor immunity for both prevention and treatment of lymphoma

    Cancer therapeutic nanovaccines are ideal tools to inhibit tumor growth and provide the body with continuous protecting immune surveillance. However, the conventional subcutaneous (SC) vaccination normally ind...

    Ling-**ao Zhang, Ying-Bo Jia, Ya-Ru Huang, Hui-Na Liu, **a-Mei Sun in Nano Research (2021)

  6. Article

    Open Access

    Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer’s Disease

    Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. No disease-modifying strategy to prevent or delay AD progression currently exists. Aβ oligomers (AβOs), rather than monomers or fibrils, ar...

    **ao-ge Liu, Lun Zhang, Shuai Lu, Dong-qun Liu, Ya-ru Huang in Journal of Nanobiotechnology (2020)

  7. Article

    Open Access

    Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer’s disease and frontotemporal dementia

    Truncated mis-disordered tau protein plays an important role in the pathogenesis of Alzheimer’s disease (AD) and frontotemporal dementia (FTD). Tau294–305, an epitope in the truncated tau, is essential for pathol...

    Mei Ji, **-xiu **e, Dong-qun Liu, **ao-lin Yu, Yue Zhang in Alzheimer's Research & Therapy (2018)